SCHEMBL6436908

SCHEMBL6436908

Cc1c(C(=O)O)cccc1-c1cccc(OCCNC(=O)OC(C)(C)C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.50
CA12 O43570 3/20 0.46
CA1 P00915 3/20 0.46
CA2 P00918 3/20 0.46
CA9 Q16790 3/20 0.46
PDCD1 Q15116 1/20 0.44
CD274 Q9NZQ7 1/20 0.44
SUCNR1 Q9BXA5 3/20 0.41
SYK P43405 1/20 0.41
EGFR P00533 1/20 0.41
ITK Q08881 1/20 0.41
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
IDO1 P14902 1/20 0.40
POLB P06746 1/20 0.40
BCHE P06276 1/20 0.40
CNR2 P34972 1/20 0.40
PPARD Q03181 1/20 0.39
PPARA Q07869 1/20 0.39
DHODH Q02127 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6437277 0.82 SYK (0.48) PDK2CA1CA2PDCD1CD274
SCHEMBL22382978 0.81 PDK2 (0.54) PDK2CA12CA1CA2CA9
SCHEMBL6436914 0.79 PTGER1 (0.44) PDK2CA12CA1CA2CA9
SCHEMBL25155264 0.79 CA12 (0.57) PDK2CA12CA1CA2CA9
SCHEMBL30343966 0.79 CA12 (0.57) PDK2CA12CA1CA2CA9
SCHEMBL613521 0.79 KMT2A (0.58) PDK2CA12CA1CA2CA9
SCHEMBL31539418 0.79 KMT2A (0.58) PDK2CA12CA1CA2CA9
SCHEMBL91150 0.78 CA12 (0.56) PDK2CA12CA1CA2CA9
SCHEMBL13270629 0.78 POLB (0.62) PDK2CA12CA1CA2CA9
SCHEMBL13162350 0.78 CA12 (0.56) PDK2CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1087943-B1 THERAPEUTIC BIARYL DERIVATIVES GLAXO GROUP LTD (GB) 2005-08-17 EP disclosed
US-6251925-B1 AN AGONISTS FOR HUMAN BETA-3 ADRENOCEPTOR GLAXO WELLCOME INC. 2001-06-26 US disclosed
EP-1087943-A1 THERAPEUTIC BIARYL DERIVATIVES GLAXO GROUP LIMITED (GB) 2001-04-04 EP disclosed
WO-1999065877-A1 THERAPEUTIC BIARYL DERIVATIVES GLAXO GROUP LIMITED (GB) 1999-12-23 WO disclosed